Multiomic Screening Unravels the Immunometabolic Signatures and Drug Targets of Age-Related Macular Degeneration
X. cui, Q. Zhao, B. Mahata, D. Wen, P. Yu-Wai-Man, X. Li
This study uses multiomic methods to identify immunometabolic pathways and drug targets in AMD, highlighting key genes and pathways involved in disease progression and potential therapeutic interventions.
bioRxiv · May 7, 2024 · PreprintImmunology